Literature DB >> 28408475

Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation.

Laura Hidalgo1, Chad M Swanson2.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) mRNA translation is a complex process that uses the host translation machinery to synthesise viral proteins. Several mechanisms for HIV-1 mRNA translation initiation have been proposed including (1) cap-dependent, eIF4E-dependent, (2) cap-dependent, cap-binding complex-dependent, (3) internal ribosome entry sites, and (4) ribosome shunting. While these mechanisms promote HIV-1 mRNA translation in the context of in vitro systems and subgenomic constructs, there are substantial knowledge gaps in understanding how they regulate viral protein production in the context of full-length virus infection. In this review, we will summarise the different translation mechanisms used by HIV-1 mRNAs and the challenges in understanding how they regulate protein synthesis during viral infection.
© 2017 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  HIV; eukaryotic gene expression; mRNA translation

Mesh:

Substances:

Year:  2017        PMID: 28408475     DOI: 10.1042/BST20160357

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

1.  Landscape Zooming toward the Prediction of RNA Cotranscriptional Folding.

Authors:  Xiaojun Xu; Lei Jin; Liangxu Xie; Shi-Jie Chen
Journal:  J Chem Theory Comput       Date:  2022-02-08       Impact factor: 6.006

Review 2.  Anomalous HIV-1 RNA, How Cap-Methylation Segregates Viral Transcripts by Form and Function.

Authors:  Kathleen Boris-Lawrie; Gatikrushna Singh; Patrick S Osmer; Dora Zucko; Seth Staller; Xiao Heng
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

3.  Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication.

Authors:  Irati Antzin-Anduetza; Charlotte Mahiet; Luke A Granger; Charlotte Odendall; Chad M Swanson
Journal:  Retrovirology       Date:  2017-11-09       Impact factor: 4.602

4.  Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K.

Authors:  Domenico Di Curzio; Mamneet Gurm; Matthew Turnbull; Marie-Josée Nadeau; Breanna Meek; Julia D Rempel; Samuel Fineblit; Michael Jonasson; Sherry Hebert; Jennifer Ferguson-Parry; Renée N Douville
Journal:  Cells       Date:  2020-06-30       Impact factor: 6.600

5.  Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.

Authors:  Marilia Rita Pinzone; D Jake VanBelzen; Sam Weissman; Maria Paola Bertuccio; LaMont Cannon; Emmanuele Venanzi-Rullo; Stephen Migueles; R Brad Jones; Talia Mota; Sarah B Joseph; Kevin Groen; Alexander O Pasternak; Wei-Ting Hwang; Brad Sherman; Anastasios Vourekas; Giuseppe Nunnari; Una O'Doherty
Journal:  Nat Commun       Date:  2019-02-13       Impact factor: 14.919

6.  Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice.

Authors:  Saumi Mathews; Amanda Branch Woods; Ikumi Katano; Edward Makarov; Midhun B Thomas; Howard E Gendelman; Larisa Y Poluektova; Mamoru Ito; Santhi Gorantla
Journal:  Mol Neurodegener       Date:  2019-03-05       Impact factor: 14.195

7.  HIV-1 hypermethylated guanosine cap licenses specialized translation unaffected by mTOR.

Authors:  Gatikrushna Singh; Bradley Seufzer; Zhenwei Song; Dora Zucko; Xiao Heng; Kathleen Boris-Lawrie
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 11.205

8.  CBP80/20-dependent translation initiation factor (CTIF) inhibits HIV-1 Gag synthesis by targeting the function of the viral protein Rev.

Authors:  Francisco García-de-Gracia; Aracelly Gaete-Argel; Sebastián Riquelme-Barrios; Camila Pereira-Montecinos; Bárbara Rojas-Araya; Paulina Aguilera; Aarón Oyarzún-Arrau; Cecilia Rojas-Fuentes; Mónica L Acevedo; Jonás Chnaiderman; Fernando Valiente-Echeverría; Daniela Toro-Ascuy; Ricardo Soto-Rifo
Journal:  RNA Biol       Date:  2020-10-25       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.